HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+12.21%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$290M
AUM Growth
+$290M
(+5.9%)
Cap. Flow
-$2.16M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.51%
Holding
174
New
37
Increased
46
Reduced
48
Closed
32
Top Buys
| 1 |
GE Vernova
GEV
|
$3.75M |
| 2 |
Amgen
AMGN
|
$3.25M |
| 3 |
Protagonist Therapeutics
PTGX
|
$3.07M |
| 4 |
Amazon
AMZN
|
$2.65M |
| 5 |
Edgewise Therapeutics
EWTX
|
$2.37M |
Top Sells
| 1 |
Insmed
INSM
|
$5.94M |
| 2 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$4.02M |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$3.97M |
| 4 |
Merus
MRUS
|
$2.14M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.06M |
Sector Composition
| 1 | Healthcare | 46.45% |
| 2 | Technology | 15.69% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Industrials | 4.98% |
| 5 | Financials | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $32M | 11.03% | 1,436,136 | – | – |
|
|
2
Amazon
AMZN
$2.44T
| $6M | 2.07% | 32,193 +14,200 | +79% | +$2.65M |
|
3
Vaxcyte
PCVX
$4B
| $5.1M | 1.76% | 44,661 +12,348 | +38% | +$1.41M |
|
4
Arcellx
ACLX
$3.85B
| $4.6M | 1.59% | 55,139 +4,099 | +8% | +$342K |
|
|
CTLT
5
DELISTED
CATALENT, INC.
CTLT
| $4.58M | 1.58% | 75,600 | – | – |
|
6
Salesforce
CRM
$245B
| $4.54M | 1.57% | 16,585 -4,600 | -22% | -$1.26M |
|
|
JNPR
7
DELISTED
Juniper Networks
JNPR
| $4.47M | 1.54% | 114,700 | – | – |
|
|
HCP
8
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.41M | 1.52% | 130,200 | – | – |
|
9
Viridian Therapeutics
VRDN
$1.5B
| $4.21M | 1.45% | 185,240 -13,244 | -7% | -$301K |
|
|
ANSS
10
DELISTED
Ansys
ANSS
| $4.08M | 1.41% | 12,800 | – | – |
|
11
XPO
XPO
$15.3B
| $4.05M | 1.4% | 37,680 +12,200 | +48% | +$1.31M |
|
|
12
Protagonist Therapeutics
PTGX
$3.67B
| $4.03M | 1.39% | 89,508 +68,279 | +322% | +$3.07M |
|
|
HES
13
DELISTED
Hess
HES
| $3.92M | 1.35% | 28,900 | – | – |
|
14
argenx
ARGX
$43.6B
| $3.88M | 1.34% | 7,154 +550 | +8% | +$298K |
|
|
AMED
15
DELISTED
Amedisys
AMED
| $3.79M | 1.31% | 39,250 | – | – |
|
|
16
GE Vernova
GEV
$167B
| $3.75M | 1.29% | +14,700 | New | +$3.75M |
|
17
Axsome Therapeutics
AXSM
$6.05B
| $3.73M | 1.29% | 41,542 -20,650 | -33% | -$1.86M |
|
|
18
Merus
MRUS
$4.98B
| $3.7M | 1.27% | 73,980 -42,738 | -37% | -$2.14M |
|
19
Apogee Therapeutics
APGE
$2.17B
| $3.63M | 1.25% | 61,788 -17,154 | -22% | -$1.01M |
|
20
Albertsons Companies
ACI
$10.9B
| $3.49M | 1.2% | 188,753 | – | – |
|
|
21
Insmed
INSM
$28.8B
| $3.32M | 1.14% | 45,447 -81,333 | -64% | -$5.94M |
|
22
Capri Holdings
CPRI
$2.45B
| $3.3M | 1.14% | 77,700 | – | – |
|
|
23
Amgen
AMGN
$155B
| $3.25M | 1.12% | +10,101 | New | +$3.25M |
|
24
Maplebear
CART
$11.4B
| $3.2M | 1.1% | 78,500 -14,488 | -16% | -$590K |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$511M
| $3.16M | 1.09% | 139,544 +12,289 | +10% | +$278K |
|